276 related articles for article (PubMed ID: 30509303)
21. Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.
Pathania R; Ramachandran S; Mariappan G; Thakur P; Shi H; Choi JH; Manicassamy S; Kolhe R; Prasad PD; Sharma S; Lokeshwar BL; Ganapathy V; Thangaraju M
Cancer Res; 2016 Jun; 76(11):3224-35. PubMed ID: 27197203
[TBL] [Abstract][Full Text] [Related]
22. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
Lin CS; Bamodu OA; Kuo KT; Huang CM; Liu SC; Wang CH; Tzeng YM; Chao TY; Yeh CT
Phytomedicine; 2018 Jul; 46():93-103. PubMed ID: 30097127
[TBL] [Abstract][Full Text] [Related]
23. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
[TBL] [Abstract][Full Text] [Related]
25. LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
Zhao Z; Sun Y; Tang J; Yang Y; Xu X
BMC Cancer; 2023 Oct; 23(1):935. PubMed ID: 37789316
[TBL] [Abstract][Full Text] [Related]
26. Development of Stemness in Cancer Cell Lines Resistant to the Anticancer Effects of Zoledronic Acid.
Yoshiyama A; Morii T; Ohtsuka K; Ohnishi H; Tajima T; Aoyagi T; Mochizuki K; Satomi K; Ichimura S
Anticancer Res; 2016 Feb; 36(2):625-31. PubMed ID: 26851017
[TBL] [Abstract][Full Text] [Related]
27. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
[TBL] [Abstract][Full Text] [Related]
28. HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells.
Li J; Yan X; Tang J; Wang Y; Tang J; Wu W; Liu M
Cell Biol Toxicol; 2019 Oct; 35(5):423-433. PubMed ID: 30706385
[TBL] [Abstract][Full Text] [Related]
29. Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer.
Kim JK; Noh JH; Eun JW; Jung KH; Bae HJ; Shen Q; Kim MG; Chang YG; Kim SJ; Park WS; Lee JY; Borlak J; Nam SW
Mol Cancer Res; 2013 Jan; 11(1):62-73. PubMed ID: 23175521
[TBL] [Abstract][Full Text] [Related]
30. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
[TBL] [Abstract][Full Text] [Related]
31. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
[TBL] [Abstract][Full Text] [Related]
32. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G
FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990
[TBL] [Abstract][Full Text] [Related]
33. Uncoupling Warburg effect and stemness in CD133
Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.
Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R
Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
36. Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells.
Lee SH; Nam HJ; Kang HJ; Samuels TL; Johnston N; Lim YC
Oncol Rep; 2015 Oct; 34(4):2065-71. PubMed ID: 26239260
[TBL] [Abstract][Full Text] [Related]
37. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.
Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A
Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
39. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.
Sun D; Yu M; Li Y; Xing H; Gao Y; Huang Z; Hao W; Lu K; Kong C; Shimozato O; Ozaki T; Zhu Y
FEBS Open Bio; 2019 Mar; 9(3):478-489. PubMed ID: 30868056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
